FOCL (29) HSDT (37) CV (44) VANI (34) ⌘ Pro Terminal →

Electromed Inc. (ELMD) — RQD Stock Rating Cockpit

$27.68 +1.47% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $27.82

Electromed Inc. (ELMD) earns a Roarable Rating of B+ (Buy) with 77/100 RQD Confidence. High-quality cash engine (78% profit margin, 24% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

📊 Historical Track Record: Scores of 77/100 (B+) historically ranked in the Top 10% of excess returns over the next 90 days (+7.8% avg 90D alpha vs SPY • 70.3% hit rate) →

ROARABLE B+ • BUY Cap $229.4M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $27.82 (+0.50%)🧬 Cannibal Buyback (-2.36% YoY Shares)⚙️ Cash Engine: 17/20 (A-) • 17.4% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 77/100 (B+) historically ranked in the Top 10% of excess returns over the next 90 days (+7.8% avg 90D alpha vs SPY • 70.3% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERBUY • B+

3-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B · Rk A-

Each axis scored 0–20

12M PRICE TARGET CONE+8.6% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ELMD)Realized 20D OHLCV Swing Band: ±6.3%

Deterministic 5-Pillar Attribution (77/100 Composite)

🔍 WHY ELMD SCORES 77/100 (B+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (23% of score)

Altman Z-Score 17.64 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9

▲ #2 Bullish Driver: Cash Engine Quality+17/20 pts (22% of score)

SEC XBRL FY 2025 (10-K): 17.4% FCF Margin ($11.1M FCF) & 78.1% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning11/20 pts (-9 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-9 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade A$27.69-1% Next Q

Q2 (-2Q)

Grade A$27.42-3.8% Next Q

Q3 (-1Q)

Grade A-$26.37+5% Next Q

Current

Grade B+$27.68+7.8% Hist 90D α

Trajectory: A (85) → B+ (77)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the ELMD Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 77/100 (B+) score, ELMD faces multiple-compression risk if 30.4x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.36% YoY Shares) — any gross margin slip below 75.6% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($28.37) or 200D SMA ($31.28) invalidates the momentum regime and cuts Target Base ($30.05) toward Bear Floor ($22.70).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $ELMD• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “ELMD Beats Next Quarter EPS Consensus (Dec 28, 2026) & Holds Above 200D SMA”

YES 77%NO 23%Trade / Inspect Odds →

RSI-14 MOMENTUMNEUTRAL RANGE

4230 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

17.64>3.0 Fortress Safe

PIOTROSKI F-SCOREHIGH QUALITY (7–9)

8 / 99-Pt Accounting

52-WEEK LASER RANGE19% OF RANGE

L: $23$27.68H: $47

1. Money & Cash Health● HEALTHY

Are profits real cash in the bank?

Real cash coming in backs up reported profits (78% profit margin and healthy balance-sheet cushion).

Factor Grade: A-RQD 17 / 20

2. Big Money & Insiders● NEUTRAL

Are whales & executives buying or selling?

Big funds and company insiders are mostly holding steady without aggressive buying or panic selling.

Factor Grade: C+RQD 27 / 40

3. Hidden Risks & Market Weather● ALL CLEAR

SEC fine-print scan & interest-rate fit

Clean SEC fine-print check with low hidden accounting risk and favorable interest-rate weather.

Factor Grade: A-RQD 33 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

3-of-3 JEV AI Jury Bullish on ELMD

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

BULLISH (85)

24.1% ROIC with 78.1% gross margin and 4.85% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

BULLISH (90)

Altman-Z 17.64 and Piotroski 8/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

BULLISH (70)

27/40 institutional & smart-money positioning score with 15/20 macro alignment.

Bull Case: Why Buyers Like ELMD

✓Strong cash generator (78% profit margin)—profits are backed by real money, not accounting tricks.
✓Company leadership has skin in the game with net positive insider conviction.
✓Clean SEC annual filing review with no major hidden accounting time-bombs.

Bear Case: What Could Go Wrong

!Broader market pullbacks can still drag down strong stocks in the short run.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (ELMD Tape Review)

✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
✓Forensic Red-Light accounting & dilution traps to review on your watchlist
✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

ELMD // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +7.66%🛡️ HOLDING TREND SUPPORT

2026-10-30O $27.95H $28.07L $26.87C $27.68VOL 36.4K

RES: $36.28SUP: $26.27SMA50: $28.37SMA200: $31.28

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ELMD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 ELMD Butterfly Map → + Track ELMD →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

23.5%/yr Implied 5Y Growth

vs. +17.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ELMD today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ELMD. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for ELMD today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ELMD)

Health Care Rank #31 of 1016 ⚔️ FOCL vs ELMD Full Matrix →

1. Head-to-Head Health Care Peer Comparison (ELMD vs. FOCL, HSDT, CV, VANI)

Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus (26 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Electromed Inc. (ELMD) ranks #31 by composite RQD confidence (77/100, grade B+) and #557 by equity capitalization ($229.4M). Within this direct 5-issuer industry benchmark cohort, VANI leads on earnings valuation at 3.9x trailing P/E, while ELMD leads on capital efficiency and profitability with 24.1% ROIC and 78.1% gross margin. ELMD currently leads its immediate peer cohort in composite quantitative strength at 77/100 (B+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
ELMD ACTIVE Electromed Inc.	B+	77/100	30.4x	78.1%	24.1%	+1.47%	$229.4M	Benchmark Subject
FOCL EDAP TMS S.A.	E	29/100	—	42.5%	-35.0%	-2.11%	$191.6M	/focl-vs-elmd →
HSDT Solana Company (Class A)	D-	37/100	—	96.0%	-35.0%	-1.31%	$146.5M	/hsdt-vs-elmd →
CV CapsoVision Inc.	D	44/100	—	52.9%	-35.0%	-1.70%	$369.2M	/cv-vs-elmd →
VANI Vivani Medical Inc.	E	34/100	3.9x	—	-35.0%	0.00%	$102.8M	/vani-vs-elmd →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-06-30 • CIK 0001488917

In its most recent audited fiscal period (FY2025, filed 2025-06-30), Electromed Inc. (ELMD) reported GAAP revenue of $64.0M (+17.0% vs. FY2024 revenue of $54.7M , and +33.1% cumulative change since FY2023) , GAAP net income of $7.5M, operating cash flow of $11.4M, and free cash flow of $11.1M (+26.8% YoY). On the balance sheet, ELMD closed FY2025 with $54.9M in total assets against $0 in total debt (Altman Z-Score: 17.64, Piotroski F-Score: 8/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-06-30	$64.0M	$7.5M	$11.4M	$11.1M	$54.9M	—
FY2024 (FY)	2024-06-30	$54.7M	$5.2M	$9.1M	$8.8M	$52.3M	—
FY2023 (FY)	2023-06-30	$48.1M	$3.2M	$1.3M	$1.3M	—	—

3. ELMD Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ELMD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Electromed Inc. (NYSE: ELMD) is rated B+ (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 77/100 at a spot price of $27.68 (+1.47% 1D, market cap $229.4M). Pillar breakdown: Fundamental Cash Engine 17/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 16/20. Across 1016 tracked Health Care issuers, ELMD ranks #31 in composite RQD confidence.

How does ELMD compare to FOCL and HSDT in the Health Care sector?

Within the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus), ELMD carries a Roarable B+ (77/100 RQD), trailing P/E of 30.4x, gross margin of 78.1%, and ROIC of 24.1%. By comparison, FOCL (EDAP TMS S.A.) holds a E grade (29/100 RQD, P/E N/A, ROIC -35.0%, cap $191.6M) and HSDT (Solana Company (Class A)) posts a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $146.5M). Among the 5-stock peer group, VANI leads on earnings multiple (3.9x) while ELMD leads on capital efficiency (24.1% ROIC).

What are the biggest fundamental strengths and SEC risk factors for ELMD?

Per ELMD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0001488917), Electromed Inc. generated $64.0M in revenue (+17.0% YoY), $7.5M in net income, and $11.1M in free cash flow against $54.9M in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (78% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is ELMD trading relative to its 50-day, 200-day, and 52-week technical levels?

ELMD last traded at $27.68 (+1.47% on volume of 26,910 shares), positioning the stock -2.43% below its 50-day simple moving average ($28.37) and -11.51% below its 200-day simple moving average ($31.28). Across its 52-week range of $23.01 to $47.40, ELMD sits at the 19.1% percentile with a 14-day RSI of 42.0 (NEUTRAL RANGE) and an implied next-earnings move of ±6.3% ($25.94 to $29.42).

ELMD Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell ELMD stock right now?

Electromed Inc. (ELMD) currently earns a Roarable Rating of B+ (Buy — BUY) with 77/100 RQD Confidence. High-quality cash engine (78% profit margin, 24% return on capital) with steady institutional support.

What is ELMD's 12-month price target and RQD AI Jury consensus?

ELMD's 12-month base price target is $30.05 (range $22.7 to $49.77), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: ELMD RQD Cockpit ELMD 12M Forecast ELMD Earnings & Move ELMD Dividends & DRIP ELMD Insiders & 13F ELMD Whale Options ELMD Profit Sankey ELMD News & Why